Endocyte (ECYT)

Add to Watchlists Create an Alert
14.04 +0.02  +0.14%   NASDAQ May 24, 12:58PM BATS Real time Currency in USD

Endocyte Revenue Quarterly YoY Growth:

7467% for Dec. 31, 2012
View Full Chart

Endocyte Revenue Quarterly YoY Growth Chart

    Endocyte Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 7467%
    Sept. 30, 2012
    June 30, 2012
    March 31, 2012
    Dec. 31, 2011
       
    Sept. 30, 2011
    June 30, 2011
    March 31, 2011
    Dec. 31, 2010
    Sept. 30, 2010 -100.0%

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    ECYT Revenue Quarterly YoY Growth Benchmarks

    Companies
    Lannett Company 31.84%
    Merck -9.04%
    Catalyst Pharmaceutical Partners

    ECYT Revenue Quarterly YoY Growth Rankings

    Overall 99th percentile
    8 of 8009
    Sector 99th percentile
    2 of 687 in Healthcare
    Industry 98th percentile
    1 of 69 in Drug Manufacturers - Specialty & Generic

    ECYT Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -100.0% Sep 2010
    Maximum 7467% Dec 2012
    Average 3683%